Lixte Biotechnology Holdings, Inc. consummated a merger with NOMAD Transportable Power Systems, Inc. on July 1, 2026, issuing 2,992,041 common shares and 50,366.07 shares of Series D Convertible Preferred Stock. The company is changing its name to Nomad Power Solutions, Inc. and its ticker symbol to NMAD on July 6, 2026. The company operates in the power systems industry and provides transportable power solutions.

On June 17, 2026, Lixte Biotechnology Holdings, Inc. issued a $6,500,000 Secured Promissory Note to NOMAD Transportable Power Systems, Inc. in connection with a previously announced merger agreement. The funds are designated to repay NOMAD's outstanding obligations to BPCP Investment Holdings, LP and for NOMAD's working capital. The Note is secured by a first-priority security interest in substantially all of NOMAD's assets and matures in 30 days, with automatic 30-day extensions while the Merger Agreement remains active. Upon closing of the merger, the principal will be offset against amounts deliverable to NOMAD. Lixte Biotechnology Holdings, Inc. operates in the biotechnology industry.

On June 11, 2026, Lixte Biotechnology Holdings, Inc. entered into a merger agreement to acquire Nomad Transportable Power Systems, Inc. through a merger subsidiary. Consideration for Nomad shares includes up to 50,500 shares of Series D Convertible Preferred Stock (issue price $1,000 per share, convertible to 50,500,000 common shares at $1.00 per share) and up to 3,000,000 shares of common stock. Closing conditions include Lixte maintaining at least $16,500,000 in unrestricted cash, the appointment of John Travaglini as CEO of the merger sub and to the Board, and stockholder approval for the preferred stock conversion and authorized share increase. Unaccredited Nomad stockholders will receive cash based on a 60-day volume-weighted average price. The company operates in the biotechnology industry.